Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergen immunotherapy (5)
  • AllergoOncology (2)
  • Allergy diagnosis (28)
  • Allied health and primary care (2)
  • Anaphylaxis (13)
  • Artificial Intelligence (2)
  • Asthma (16)
  • Basic immunology (3)
  • Biologicals (5)
  • Biomarkers (3)
  • COVID19 (2)
  • Dermatology (20)
  • Drug allergy (13)
  • x ENT (4)
  • Environmental allergy and climate change (1)
  • Eosinophilic esophagitis (1)
  • Epidemiology (4)
  • Food allergy (18)
  • Genomics and proteomics (1)
  • Immune deficiencies and autoimmunity (7)
  • Immunomodulation and nutrition (1)
  • Infections (5)
  • Insect venom hypersensitivities (4)
  • Mastocytosis and mast cells (1)
  • Microbiome (1)
  • Occupational allergy (2)
  • One Health (1)
  • Pediatrics (13)
  • Prevention (2)
Poster available until
Poster categories
  • x e-Thematic Poster Session (4)
  • Thematic Poster Session (20)
keywords
Session Reference
4 results
Thumbnail

000734 - A Systematic Review of Multidimensional Predictors for Refractory Chronic Rhinosinusitis

Thumbnail

000773 - Stratification Value of Nasal Brushing Arachidonate 15-Lipoxygenase in Stapokibart (CM310) Treatment for Patients with Seasonal Allergic Rhinitis: Results from MERAK

Thumbnail

000788 - Efficacy of Omalizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps and Association with Local Immunoglobulin E

Thumbnail

D3.97 - Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM